 | Up a level |
Palmer, Daniel H 
ORCID: 0000-0002-7147-5703, Ross, Paul J, Silcocks, Paul, Greenhalf, William ORCID: 0000-0002-1865-3195, Faluyi, Olusola Olusesan, Ma, Yuk Ting, Wadsley, Jonathan, Rawcliffe, Charlotte Louise, Valle, Juan W and Neoptolemos, John P
(2018)
ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma.
.
Shaw, Richard J ORCID: 0000-0002-5157-4042, Butterworth, Christopher J ORCID: 0000-0002-5025-7467, Silcocks, Paul, Tesfaye, Binyam T, Bickerstaffe, Matthew, Jackson, Richard, Kanatas, Anastios, Nixon, Peter, McCaul, James, Praveen, Prav et al (show 10 more authors)
(2019)
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery.
International journal of radiation oncology, biology, physics, 104 (3).
pp. 530-539.
Shaw, Richard ORCID: 0000-0002-5157-4042, Butterworth, Christopher ORCID: 0000-0002-5025-7467, Tesfaye, Binyam, Bickerstaff, Matthew, Dodd, Susanna ORCID: 0000-0003-2851-3337, Smerdon, Gary, Chauhan, Seema, Brennan, Peter, Webster, Keith, McCaul, James et al (show 3 more authors)
(2018)
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: study protocol for a randomised controlled trial.
TRIALS, 19 (1).
22-.
Shaw, Richard ORCID: 0000-0002-5157-4042, Tesfaye, Binyam, Bickerstaff, Matt, Silcocks, Paul and Butterworth, Christopher ORCID: 0000-0002-5025-7467
(2017)
Refining the definition of mandibular osteoradionecrosis in clinical trials: The cancer research UK HOPON trial (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis).
Oral Oncology, 64.
pp. 73-77.